Gary G Gemignani
CIK 1512256 · Executive Vice Pres. & CFO · last filed 2023-02-16
Gary G Gemignani is an Executive Vice Pres. & CFO who has filed 8 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider was granted $12.1K of BJDX on Feb 16, 2023. Current disclosed insider exposure totals $134.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$134.5K
3
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BJDX | Director | 27,500 | $4.89 | $134.5K | $0 | 3 | 2023-02-16 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Executive Vice Pres. & CFO | — | — | — | $0 | 3 | 2018-01-23 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2016-01-25 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-16 | BJDX | Grant (A) | +27,500 | $12.1K | EDGAR |
| 2022-03-23 | BJDX | Grant (A) | — | $0 | EDGAR |
| 2021-12-17 | BJDX | Grant (A) | — | $0 | EDGAR |
| 2018-01-23 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-01 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-25 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-17 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |